A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects

NCT03056326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Cystic Fibrosis Bronchiectasis
Cystic Fibrosis

Interventions

DRUG: CHF6333 (Part 1 - SAD)
DRUG: Placebo (Part 1 - SAD)
DRUG: CHF6333 (Part 2 - MAD)
DRUG: Placebo (Part 2 - MAD)

Sponsor

Chiesi Farmaceutici S.p.A.